BioRegenx, Inc.
BRGX
$0.0129
$0.001917.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.21M | -6.33M | -3.37M | -2.90M | -1.74M |
| Total Depreciation and Amortization | 1.64M | 1.07M | 198.90K | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | 39.30K | 30.70K | 5.90K | 5.90K | 5.90K |
| Total Other Non-Cash Items | 2.82M | 5.31M | 3.11M | 2.78M | 2.24M |
| Change in Net Operating Assets | 564.80K | 519.60K | 326.20K | 5.60K | 577.60K |
| Cash from Operations | 851.90K | 599.60K | 269.90K | -104.70K | 1.09M |
| Capital Expenditure | -138.00K | -138.00K | -537.00K | 51.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -11.00K |
| Cash Acquisitions | 1.40K | 1.40K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.70K | -2.70K | -18.45M | -- | -- |
| Cash from Investing | -139.20K | -139.20K | -18.99M | 51.40K | -11.00K |
| Total Debt Issued | 501.60K | 516.00K | 720.70K | 84.00K | -1.56M |
| Total Debt Repaid | 104.40K | 96.40K | 30.40K | -51.10K | -196.00K |
| Issuance of Common Stock | -- | 63.20K | 477.30K | 815.00K | 815.00K |
| Repurchase of Common Stock | -815.10K | -815.10K | -815.10K | -815.10K | -44.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 18.44M | -- | -- |
| Cash from Financing | -209.10K | -139.40K | 18.85M | 32.90K | -986.60K |
| Foreign Exchange rate Adjustments | -1.10K | 1.50K | 15.90K | 19.70K | 19.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 502.80K | 322.70K | 155.40K | -700.00 | 109.40K |
